Secondary malignancy after allogeneic stem cell transplantation: Incidence and risk factors.

被引：0
|
作者：
Hosing, C [1 ]
Saliba, RM [1 ]
De Lima, M [1 ]
Giralt, S [1 ]
Ghosh, S [1 ]
Hsu, Y [1 ]
Anderlini, P [1 ]
Hymes, SR [1 ]
Andersson, B [1 ]
Khouri, IF [1 ]
Champlin, R [1 ]
Couriel, D [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1123
引用
收藏
页码：327A / 327A
页数：1
相关论文
共 50 条
  • [31] The incidence, risk factors and outcomes of primary poor graft function after allogeneic hematopoietic stem cell transplantation
    Gao, Fei
    Shi, Jimin
    Luo, Yi
    Tan, Yamin
    Lai, Xiaoyu
    Yu, Jian
    Huang, He
    Zhao, Yanmin
    BONE MARROW TRANSPLANTATION, 2019, 54 : 249 - 250
  • [32] HEMORRHAGIC CYSTITIS IN CHILDREN AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: INCIDENCE, TREATMENT, OUTCOME, AND RISK FACTORS
    Celik, Nur Ayca
    Ileri, Talia
    Ince, Elif
    Cakmakli, Hasan Fatih
    Burgu, Berk
    Karahan, Zeynep Ceren
    Sahap, Seda Kaynak
    Dumlupinar, Ebru
    Ertem, Mehmet
    BONE MARROW TRANSPLANTATION, 2024, 59 : 611 - 612
  • [33] Incidence, Risk Factors, and Outcomes of Primary Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation
    Zhao, Yanmin
    Gao, Fei
    Shi, Jimin
    Luo, Yi
    Tan, Yamin
    Lai, Xiaoyu
    Yu, Jian
    Huang, He
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (09) : 1898 - 1907
  • [34] Incidence and risk factors for developing limbic encephalitis in allogeneic stem cell transplantation.
    Braden, Christopher D.
    Alore, Patrick L.
    Stiff, Patrick J.
    Rodriguez, Tulio E.
    Parthasarathy, Mala
    Toor, Amir A.
    Macken, Micheal P.
    BLOOD, 2006, 108 (11) : 826A - 826A
  • [35] SEVERE HEMORRHAGIC CYSTITIS (HC) AFTER ALLOGENEIC HEMATOPOETIC STEM CELL TRANSPLANTATION (HSCT): INCIDENCE AND RISK FACTORS
    Smith, A. R.
    Tolar, J.
    DeFor, T. E.
    Weisdorf, D. J.
    MacMillan, M. L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 32 - 33
  • [36] Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation
    Ljungman, Per
    Perez-Bercoff, Lena
    Jonsson, Jerker
    Avetisyan, Gayane
    Sparrelid, Elda
    Aschan, Johan
    Barkholt, Lisbeth
    Larsson, Kajsa
    Winiarski, Jacek
    Yun, Zhibing
    Ringden, Olle
    HAEMATOLOGICA, 2006, 91 (01) : 78 - 83
  • [37] Risk factors for CMV retinitis after allogeneic blood stem cell transplantation
    Larsson, K
    Ljungman, P
    Dekker, A
    Rovira, M
    Einsele, H
    Maertens, J
    Arcese, W
    Békàssy, A
    De La Cámara, R
    Graphakos, S
    Rio, B
    Arvidsson, J
    Wulffraat, N
    Cordonnier, C
    BONE MARROW TRANSPLANTATION, 2002, 29 : S53 - S53
  • [38] Renal dysfunction after allogeneic stem cell transplantation: Risk factors and outcome
    Oshima, K
    Kanda, Y
    Sato, H
    Watanabe, T
    Hosoya, N
    Chiba, S
    Kurukawa, M
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 35 - 36
  • [39] Allogeneic hematopoietic stem cell transplantation and the risk for transmission of heritable malignancy
    McMilin, KD
    TRANSFUSION, 2002, 42 (04) : 495 - 504
  • [40] Malignancy after heart transplantation:: Incidence, prognosis and risk factors
    Crespo-Leiro, M. G.
    Alonso-Pulpon, L.
    de Prada, J. A. Vazquez
    Almenar, L.
    Arizon, J. M.
    Brossa, V.
    Delgado, J. F.
    Fernandez-Yanez, J.
    Manito, N.
    Rabago, G.
    Lage, E.
    Roig, E.
    Diaz-Molina, B.
    Pascual, D.
    Muniz, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (05) : 1031 - 1039
12345